Rombotis Spiro George 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed May 22, 2013
Insider Transaction Report
Form 4
Rombotis Spiro George
DirectorPresident & C.E.O.
Transactions
- Purchase
Common Stock, $0.001 par value per share
2013-05-21$3.00/sh+100,000$300,000→ 268,292 total
Footnotes (1)
- [F1]The total number of shares of common stock beneficially owned by the Reporting Person has been reduced due to an inadvertent mathematical error in a prior report. Of the shares of common stock reported, 142 shares are held indirectly by Mr. Rombotis through his IRA account and 30,714 shares are represented by unvested restricted stock units.